Features & Specs
- Anti-MMAE/DXD antibodies and anti-idiotypic antibodies;
- High specificity & affinity;
- High sensitivity & stability;
- Positive reference of ADCs preclinical / clinical immunogenicity.
Already a member? Login here
The activity of anti-MMAE monoclonal antibody (Cat.No.MME-M5252) is verified by binding to Disitamab Vedotin (RC-48) with a linear range of 0.1-2 ng/mL.